Interim Study Investigates The Risk Of Avandia Drug
There has been a debate over Avandia (Rosiglitazone), which is used in treating diabetes. It is made by GlaxoSmithKline (GSK) and earned 1.4 billion US dollars in sales last year. The aim of a drug trial was to reveal if Avandia medication raises the risk of heart attack and death from cardiovascular problems in patients [...]





